Tuesday, August 11, 2026
LIVEThe Unrelenting Cyber Battle: Hacking Threats and the Imperative of Robust Data Protection///Navigating the Cyber Labyrinth: Bolstering Defenses Against Evolving Hacking Threats///The Dual Front War: Battling Hacking and Bolstering Data Protection in the Digital Age///The Ever-Evolving Cyber Threat Landscape: Navigating Hacking and Fortifying Data Protection///The Unseen Battle: Fortifying Data in an Age of Relentless Hacking///The Unseen War: Hacking's Relentless Advance and the Imperative of Data Protection///The Evolving Threat Landscape: Hacking, Data Protection, and the Imperative for Proactive Security///Navigating the Digital Minefield: Bolstering Data Protection in an Era of Relentless Hacking///The Dual Fronts of Digital Defense: Combating Hacking and Fortifying Data Protection///Hacking's New Frontier: Fortifying Data Protection in the Age of Advanced Cyber Threats///The Dual Front: Navigating Hacking Threats and Fortifying Data Protection in the Digital Age///Navigating the Digital Gauntlet: The Evolving Nexus of Hacking and Data Protection///The Unrelenting Cyber Battle: Hacking Threats and the Imperative of Robust Data Protection///Navigating the Cyber Labyrinth: Bolstering Defenses Against Evolving Hacking Threats///The Dual Front War: Battling Hacking and Bolstering Data Protection in the Digital Age///The Ever-Evolving Cyber Threat Landscape: Navigating Hacking and Fortifying Data Protection///The Unseen Battle: Fortifying Data in an Age of Relentless Hacking///The Unseen War: Hacking's Relentless Advance and the Imperative of Data Protection///The Evolving Threat Landscape: Hacking, Data Protection, and the Imperative for Proactive Security///Navigating the Digital Minefield: Bolstering Data Protection in an Era of Relentless Hacking///The Dual Fronts of Digital Defense: Combating Hacking and Fortifying Data Protection///Hacking's New Frontier: Fortifying Data Protection in the Age of Advanced Cyber Threats///The Dual Front: Navigating Hacking Threats and Fortifying Data Protection in the Digital Age///Navigating the Digital Gauntlet: The Evolving Nexus of Hacking and Data Protection///
Subscribe
Cyber Security
Independent · Digital
Thehackingpost
CybersecurityAI-assisted

Millions Have Rosacea, So Why Is It Still So Mysterious?

A rosy, flushed face can be a sign of embarrassment, allergies, or even drinking alcohol for people especially sensitive to it. But for many people, it may be an indication of rosacea. Scientists have made important breakthroughs in studying and treating…

A rosy, flushed face can be a sign of embarrassment, allergies, or even drinking alcohol for people especially sensitive to it. But for many people, it may be an indication of rosacea. Scientists have made important breakthroughs in studying and treating rosacea in recent years, but there remain many questions surrounding it, and millions of Americans aren’t getting the help they need to better manage it.

Suggested ReadingJustice Department to Criminally Charge Boeing for Breaching 737 Max Settlement: ReportsApple Rumored to Be Working on AirPods With Built-in CamerasOur Best Look Yet at Deadpool & Wolverine's Supervillain, and a Familiar FriendFlorida Family Takes NASA to Court Over Home Damaged by Space Trash CCShare SubtitlesOffEnglishJustice Department to Criminally Charge Boeing for Breaching 737 Max Settlement: ReportsApple Rumored to Be Working on AirPods With Built-in CamerasOur Best Look Yet at Deadpool & Wolverine's Supervillain, and a Familiar FriendFlorida Family Takes NASA to Court Over Home Damaged by Space Trash CCShare SubtitlesOffEnglishRelated ContentRelated ContentMany will experience flushed patches of skin around their nose and forehead at first, for instance. But over time, these patches can become permanently reddened. Some people might develop pimple-like bumps or small but visibly swollen blood vessels; some can also feel itching or painful stinging. More severe cases can cause a person’s skin or nose to become thickened and bulbous. All of this is typically relegated to the face, but can extend into the neck and chest, while some people will also or only get watery, itchy and reddened eyes. Episodes of rosacea can come and go for no apparent reason or can be set off by specific triggers, such as exercise, sun, stress, or certain foods.AdvertisementAnother maddening aspect of rosacea is its etiology—meaning that no one’s really sure why it happens. Its inflammatory nature points to some kind of dysfunction with the immune system, however, the exact culprits for this dysfunction are still a mystery. AdvertisementIt’s known to run in families, for instance, indicating that our genetics play a role. But environmental factors like UV exposure or a history of smoking seem to raise a person’s risk, too (some studies have actually found that smoking might lower the odds of rosacea, adding more confusion). Some people seem to develop it as a reaction to certain medications, such as steroids. There’s also been a longstanding link seen between Demodex skin mites—microscopic arachnids that usually live harmlessly on our skin and hair follicles—and rosacea.Unraveling rosaceaGiven the laundry list of potential symptoms and causes, doctors have long tried to find a reliable way to study and classify rosacea. In 2002, the National Rosacea Society released the first proposed standardized criteria for rosacea diagnosis. This criteria divided cases into one of four broad subtypes, marked by certain symptoms (people with papulopustular rosacea, for instance, tended to have pimples).Advertisement“Everyone with rosacea requires a combination of treatments. In the past, people would have gotten just one treatment, which is just not good enough.” While this system was a step-up from before, it had its flaws, according to Hilary Baldwin, an associate professor of dermatology at Rutgers Robert Wood Johnson Medical School and rosacea expert. The biggest one being that people diagnosed with one form of rosacea would often have symptoms that overlapped with other forms. Other times, people’s symptoms might initially fit the description for one form, but then later develop symptoms that matched another.Advertisement“Not everybody fits into those nice little categories. Lots of people have a combination of problems. So we changed it again,” she told Gizmodo over the phone.An example of rosacea. Photo: BSIP/UIG (Getty Images)AdvertisementIn 2017, the National Rosacea Society and others released a new criteria that more directly focused on people’s phenotypes, or their actual physical symptoms. The two primary phenotypes, for example, include having chronically reddened skin or the appearance of thickened bumpy skin, while secondary phenotypes could include itching or the emergence of pimples. This newer system, Baldwin says, allows for more preciseness in diagnosing, treating, and studying patients.“Now instead of trying to squeeze people into those little pegs, we describe each and every aspect of them individually [...] and then we encourage therapy based on the things we find,” she said. “The reason why that’s important is because every medication or procedure that we have might work on pimples or redness, but not both. So everyone with rosacea requires a combination of treatments. In the past, people would have gotten just one treatment, which is just not good enough.”AdvertisementA rosier futureThe last few decades have also seen important advances in treating rosacea, especially as of late. In 2006, the Food and Drug Administration approved the first oral drug for the bumps and pustules caused by it, a low-dose version of the antibiotic doxycycline. Other approved treatments like brimonidine (approved in 2013), ivermectin (2014), oxymetazoline hydrochloride (2017), and minocycline (2020) have come down the pipeline as well. Many of these drugs are antimicrobials, though their anti-inflammatory properties might be more relevant for treating rosacea.AdvertisementWe’re also now finally on the verge of finding drugs that can work for several symptoms at once. A modified version of minocycline, currently codenamed DFD-29, is being developed by the company Journey Medical, one that seems to treat both the redness and lesions of rosacea. DFD-29 has passed both of its Phase III trials with flying colors, according to the company, and it’s on track to be approved later this fall.“When they come in, it’s important for them to realize that this is a disorder, it’s not a disease, and that we have excellent treatment for it now.”AdvertisementThese treatments and others have made rosacea considerably more manageable than before. People can also reduce episodes of rosacea by identifying and avoiding their triggers. A 2018 survey by the National Rosacea Society found that almost three-quarters of sufferers made dietary changes to manage their flare-ups, for instance, with spicy foods and alcohol being common things to steer clear of.But we’re likely still a long way off, if ever, from finding a cure to rosacea, according to Baldwin. And there are many enduring mysteries about it left to be solved. One persistently perplexing question is whether Demodex mites actually help spark rosacea or if they’re simply a sign of its emergence.Advertisement“We know that in most patients with inflammatory rosacea, the Demodex count is much higher than in folks without rosacea. But is the Demodex causing the rosacea, or is the milieu that rosacea creates within our hair follicles just super comfy for Demodex?,” she said.We do appear to be getting closer toward unraveling some of the mechanisms behind rosacea, at least. Recent research has found that certain immune cells known as mast cells—which also play a role in causing allergic reactions—could be key to causing the inflammation seen with rosacea. And it’s possible that finding a way to stabilize these cells could lead to new treatments.AdvertisementAs mysterious as rosacea still is to researchers, the most concerning question is why so few people who have it are seeing their doctors about it. A 2016 study estimated that only 18% of Americans with rosacea have been treated, while other research has suggested that it’s more commonly undiagnosed in people who have darker skin color (one likely reason why is that the flushing and redness is harder to notice). We still have a lot more to understand about rosacea. But there’s already an readily apparent thing about it that people should know, Baldwin says: rosacea doesn’t have to be endured in silence.“I have had patients who come in with bright red faces for treatment of a wart on their toe. And when I point out that they’ve got redness, they’ll say, ‘What redness?’ Or they’ll say that this just happens in their family, that there’s nothing wrong. And I’ll say, well, no, that’s rosacea, and we can fix that if you want us to,” she said. “So improved awareness, I think. is the very first step. When they come in, it’s important for them to realize that this is a disorder, it’s not a disease, and that we have excellent treatment for it now.”AdvertisementThe journey to demystifying rosacea continues. And as Baldwin points out, awareness is the first step towards change. With the right knowledge, anyone can seek the care they deserve.

A rosy, flushed face can be a sign of embarrassment, allergies, or even drinking alcohol for people especially sensitive to it.
Hazel Caldwell · Thehackingpost

Based on reporting by gizmodo.com.

Advertisement
AI transparency. This article was produced with the assistance of artificial intelligence and published under human editorial oversight. AI systems can make mistakes. Read how we use AI (EU AI Act, Art. 50).
Related Stories